知Yizhi Daily
← Back to this edition

World

WHO Approves Clinical Trials for Two New Ebola Vaccines

Edition 2026-11-05 · 08:00 Beijing time

The WHO has approved clinical trials for two new vaccines targeting the Bundibugyo strain of Ebola. The Democratic Republic of Congo is facing the fastest-spreading outbreak in its history; the strain has killed more than 5,300 people since May. Existing Ebola vaccines were not designed for this strain, and trial results are expected in early 2027.

A WHO expert panel on Monday recommended adding two vaccine trials to respond to the Bundibugyo Ebola outbreak in the Democratic Republic of Congo. WHO Director-General Tedros Adhanom Ghebreyesus said a trial that began last month used the Ervebo vaccine, but that vaccine is approved for the Zaire strain of Ebola, not Bundibugyo.

The two new vaccines entering trials specifically target the Bundibugyo virus and were developed by the University of Oxford in partnership with the Serum Institute of India and Moderna. The trials are being led by the DRC’s National Institute of Biomedical Research, with support from the WHO and other partners, and results are expected in early 2027.

According to data from the Africa Centers for Disease Control and Prevention, 10,444 cases of the Bundibugyo virus have been confirmed, making it the fastest-spreading outbreak in the DRC’s history. Due to the lack of dedicated vaccines and treatments, the strain has a case fatality rate of 50 percent and has killed more than 5,300 people since May, mostly in the DRC. Kenya has reported nine cases and two deaths, while Nigeria has confirmed one case.

Tedros stressed that vaccines cannot replace current measures such as early treatment, contact tracing, isolation, safe and dignified burials, and community engagement. He also called on some countries to lift travel restrictions, arguing that such measures punish countries that report transparently and weaken the response. The WHO is supporting all of the DRC’s neighboring countries in guarding against cross-border spread. A British healthcare worker infected with Ebola in the DRC is in stable condition and will be flown back to Britain for specialist treatment.

Original sources

Al Jazeera ↗
Back to this editionOpen interactive reader